STOCK TITAN

1,902,201 Outset Medical (OM) shares held via BML fund

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Outset Medical, Inc. reports a major shareholder’s existing stake. A 10% owner associated with BML Investment Partners, L.P. reports indirect beneficial ownership of 1,902,201 shares of Outset Medical common stock as of 02/12/2026. These shares are held by BML Investment Partners, L.P., whose general partner is BML Capital Management, LLC, managed by Mr. Leonard. He exercises investment and voting control over the fund’s shares but disclaims beneficial ownership except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Leonard Braden Michael

(Last) (First) (Middle)
65 E CEDAR - SUITE 2

(Street)
ZIONSVILLE IN 46077

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/12/2026
3. Issuer Name and Ticker or Trading Symbol
Outset Medical, Inc. [ OM ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 1,902,201 I Holdings of BML Investment Partners, L.P.(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Braden M Leonard 02/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Outset Medical (OM) Form 3 filing report about share ownership?

The Form 3 reports indirect beneficial ownership of 1,902,201 Outset Medical common shares. The shares are held by BML Investment Partners, L.P., with investment and voting control exercised by Mr. Leonard through BML Capital Management, LLC as general partner.

Who is the reporting person in the Outset Medical (OM) Form 3 filing?

The reporting person is Leonard Braden Michael, associated with BML Capital Management, LLC. He is identified as a 10% owner of Outset Medical through indirect holdings in BML Investment Partners, L.P., over which he exercises investment and voting control.

How are the 1,902,201 Outset Medical (OM) shares held according to the Form 3?

The 1,902,201 shares of Outset Medical common stock are held indirectly through BML Investment Partners, L.P. BML Capital Management, LLC is the fund’s general partner, and Mr. Leonard manages BML Capital, exercising investment and voting control over these shares.

Does the Outset Medical (OM) Form 3 show any new stock transactions?

The Form 3 reflects beneficial ownership of existing holdings rather than new transactions. It lists 1,902,201 common shares held indirectly through BML Investment Partners, L.P., serving as an initial statement of ownership for a 10% owner.

What ownership disclaimer does Mr. Leonard make in the Outset Medical (OM) Form 3?

Mr. Leonard disclaims beneficial ownership of shares held by BML Investment Partners, L.P., except to the extent of his pecuniary interest. Although he controls investment and voting decisions, he clarifies limits on his beneficial ownership of the fund’s Outset Medical shares.

Outset Medical, Inc.

NASDAQ:OM

OM Rankings

OM Latest News

OM Latest SEC Filings

OM Stock Data

69.04M
16.86M
2.7%
103.3%
10.98%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SAN JOSE